Category: Finance
-
$50M Challenge Seeks Quantum Life Science Applications
A new challenge competition seeks life science research applications for quantum computing that take advantage of the technology’s unique computational properties.
-
Infographic – Six Generative A.I. Applications
As our infographic indicates, generative A.I. can be applied in a range of industries, particularly in design and discovery functions.
-
Start-Up Licenses Protein Therapy Tech, Raises $50M
A new company making antibodies that degrade disease-causing proteins on and outside cell surfaces is raising $50 million in its first venture funding round.
-
Infographic – A.I. Venture Funds Tick Up in Q4 2022
A new report on venture funding for artificial intelligence start-ups shows global investment dollars rose in the fourth quarter of 2022, the first increase in 18 months.
-
Post-Surgical Fluid Cancer Analytics Company Gains $8M
A start-up company developing liquid biopsies for diagnosing cancer by analyzing fluids drained from a patient after surgery is raising $8 million in seed funds.
-
Infographic – Tech Layoffs Jump This Year
Since the start of 2023, layoffs in technology industries worldwide rose markedly, continuing a trend that began in the fall of 2022.
-
PCORI Funds Personal Dialysis Model Assessment
A team from an academic medical center and research institute are evaluating a personalized dialysis model for people with kidney disease, but with still some kidney functions.
-
Fox Foundation Funds New Genetic Variation Targets for Parkinson’s
A Parkinson’s disease organization is giving a grant to a neurodegenerative therapies developer that targets new groups of underlying disease-causing genetic changes.
-
State Grant Supports Osteoarthritis Gene Therapy Trial
A California state agency is funding a clinical trial of an experimental gene therapy for reducing inflammation in knee joints of people with osteoarthritis.
-
Psychoactive Drug Start-Up Raises $40M in Early Funds
A new company is underway developing drugs to treat PTSD and other disorders with psychoactive compounds claimed to be safer than current psychedelics.